|
CN103965119A
|
|
Zinc binding group-containing irreversible EGFR tyrosine kinase inhibitor
|
|
CN103965174A
|
|
Zinc binding group-containing quinazolinyl EGFR tyrosine kinase inhibitor
|
|
CN103965106A
|
|
Quinolyl EGFR tyrosine kinase inhibitor containing zinc binding group
|
|
CN103965167A
|
|
Imidazole carboxylic acid derivative
|
|
CN103965180A
|
|
Benzenesulfonamideoxazole and thiazole kinase inhibitor
|
|
CN103965170A
|
|
Benzene sulfonamide pyrazole kinase inhibitor
|
|
CN103936730A
|
|
Benzenesulfonamide thiazole kinases inhibitor
|
|
CN103936728A
|
|
Thiazole kinase inhibitor
|
|
CN103159736A
|
|
Substitutional pyrazol kinase inhibitor
|
|
CN103373997A
|
|
Zinc binding group containing pyridonaphthyridine inhibitor for HDAC (Histone Deacetylase) and mTOR (Mammalian Target of Rapamycin)
|
|
CN103374021A
|
|
Zinc binding group containing pyridopyrimidin inhibitor for HDAC (Histone Deacetylase) and mTOR (Mammalian Target of Rapamycin)
|
|
CN103342700A
|
|
11[beta]-hydroxysteroid dehydrogenase type 1 inhibitor
|
